News

Client News Synpromics wins best emerging UK synthetic biotech company at OBN Awards 5th October 2017 Client News Edison issues free strategic overview on future of T-cell therapies for cancer 28th September 2017 Client News Medherant signs agreement with leading Japanese transdermal patch company for evaluation of its TEPI Patch® drug delivery system 27th September 2017 Client News NPL re-launches to accelerate access to new health innovations 26th September 2017 Client News Synpromics Announces Gene Therapy Research Partnership with Solid Biosciences 20th September 2017 Client News Client News Press release story title: Cofactor Genomics announces $18M funding in an oversubscribed Series-A round to bring RNA to Precision Medicine 19th September 2017 Client News Cypralis granted new Innovate UK feasibility stage award to develop cyclophilin inhibitors targeting fibrotic diseases 18th September 2017 Client News Scientists present positive progress in the development of a new class of broad-spectrum organogold antibiotics 12th September 2017 Client News Synpromics expands facilities to meet demand for revolutionary gene control technology 11th September 2017 Client News ReViral initiates Phase 2a study of RV521 for treatment of Respiratory Syncytial Virus

Challenge trial will evaluate RV521 in approximately 70 volunteers

5th September 2017